Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a...

Area of Science:

• Pharmacology
• Metabolic Diseases
• Molecular Biology

Background:

• The precise mechanisms by which selective peroxisome proliferator-activated receptor gamma modulators (sPPARγMs) improve insulin sensitivity remain incompletely understood.
• Investigating tissue-selective compound distribution is crucial for understanding sPPARγM efficacy and safety.

Purpose of the Study:

• To elucidate the insulin-sensitizing mechanisms of sPPARγMs using INT131 as a probe.
• To examine the role of tissue-selective distribution and peroxisome proliferator-activated receptor gamma (PPARγ) regulation in INT131's effects.

Main Methods:

• Oral glucose and insulin tolerance tests were performed in db/db and DIO mice.
• INT131's effects on brown adipose tissue (BAT) and white adipose tissue (WAT) browning were assessed.
• Pharmacokinetic analysis was conducted to determine tissue distribution and elimination rates.

Main Results:

• INT131 demonstrated insulin-sensitizing effects comparable to rosiglitazone (RSG) but with enhanced WAT browning and BAT-specific gene expression.
• INT131 showed preferential distribution in adipose tissues and skeletal muscle, with lower liver abundance, avoiding hepatomegaly and hepatic steatosis.
• INT131 exhibited a longer residency time in target tissues compared to RSG.

Conclusions:

• Tissue-selective distribution is a key factor underlying the selective PPARγ modulation by INT131.
• Developing sPPARγMs that favor adipose tissue distribution may lead to safer and more effective treatments for insulin resistance and diabetes.